[{"NetIncomeLoss_2_Q2_USD":117000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":3200000.0,"OperatingLeaseLiability_0_Q2_USD":93500000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":1400000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":4400000.0,"InterestPaidNet_2_Q2_USD":5800000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":4600000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":3200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":126600000.0,"Depreciation_2_Q2_USD":4200000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":137100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":11200000.0,"AssetsCurrent_0_Q2_USD":1146200000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":6000000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":288600000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":96500000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":4500000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":2400000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":19100000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":15800000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":419500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":10900000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":3200000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":6000000.0,"IncomeTaxesPaidNet_2_Q2_USD":0.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":421200000.0,"CommonStockSharesIssued_0_Q2_shares":93200000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":1800000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":214300000.0,"Assets_0_Q2_USD":1515600000.0,"Investments_0_Q2_USD":1197400000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1842200000.0,"EarningsPerShareBasic_1_Q2_USD":0.86,"EarningsPerShareBasic_2_Q2_USD":1.26,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":-5200000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":11300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":97600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":98200000.0,"AccountsReceivableNetCurrent_0_Q2_USD":148400000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":5100000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3600000.0,"CommonStockValue_0_Q2_USD":100000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":195200000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":17.0,"DebtInstrumentUnamortizedDiscountPremiumNet_0_Q2_USD":91800000.0,"Liabilities_0_Q2_USD":684400000.0,"DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_2_Q2_USD":0.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":139200000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":80900000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":19100000.0,"CostsAndExpenses_2_Q2_USD":404000000.0,"CostsAndExpenses_1_Q2_USD":225800000.0,"ConvertibleDebtCurrent_0_Q2_USD":419500000.0,"OtherAssetsCurrent_0_Q2_USD":27500000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4700000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":120200000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":85600000.0,"OtherAssetsNoncurrent_0_Q2_USD":3600000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":415100000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":84300000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-5100000.0,"ShareBasedCompensation_2_Q2_USD":52300000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":72100000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquireRestrictedInvestments_2_Q2_USD":0.0,"AmortizationOfFinancingCosts_2_Q2_USD":700000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":122100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":83200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":29500000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":52300000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":157100000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":15800000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2_Q2_USD":46000000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_1_Q2_USD":46000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":92800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":93000000.0,"EarningsPerShareDiluted_1_Q2_USD":0.81,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":10600000.0,"NonoperatingIncomeExpense_2_Q2_USD":-13400000.0,"NonoperatingIncomeExpense_1_Q2_USD":6600000.0,"InterestExpense_2_Q2_USD":16500000.0,"InterestExpense_1_Q2_USD":8300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":418300000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.058,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":2700000.0,"OperatingLeasePayments_2_Q2_USD":4300000.0,"DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0_Q2_USD":193500000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":900000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":44600000.0,"NetIncomeLoss_1_Q2_USD":79600000.0,"LiabilitiesCurrent_0_Q2_USD":573000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.2,"CommonStockSharesOutstanding_0_Q2_shares":93200000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":21800000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":19100000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"InterestReceivableCurrent_0_Q2_USD":3700000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":34800000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":11600000.0,"DebtInstrumentFaceAmount_0_Q2_USD":517500000.0,"DeferredFinanceCostsNet_0_Q2_USD":6200000.0,"CommonStockSharesAuthorized_0_Q2_shares":220000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":539500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":302400000.0,"OperatingIncomeLoss_2_Q2_USD":135500000.0,"OperatingIncomeLoss_1_Q2_USD":76600000.0,"EquitySecuritiesFvNiRestricted_0_Q2_USD":50700000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":530300000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":533200000.0,"InventoryNet_0_Q2_USD":22000000.0,"PreferredStockValue_0_Q2_USD":0.0,"OperatingLeaseCost_2_Q2_USD":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1515600000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":9200000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":27100000.0,"OtherLiabilitiesCurrent_0_Q2_USD":16400000.0,"StockholdersEquity_0_Q2_USD":831200000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":6000000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":418300000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1015700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":302800000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":128300000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":4300000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200803"}]